Rescue of Methyl-CpG Binding Protein 2 Dysfunction-induced Defects in Newborn Neurons by Pentobarbital

Dongliang Ma, Su In Yoon, Chih Hao Yang, Guillaume Marcy, Na Zhao, Wan Ying Leong, Vinu Ganapathy, Ju Han, Antonius M J Van Dongen, Kuei Sen Hsu, Guo Li Ming, George J. Augustine, Eyleen L K Goh

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Rett syndrome is a neurodevelopmental disorder that usually arises from mutations or deletions in methyl-CpG binding protein 2 (MeCP2), a transcriptional regulator that affects neuronal development and maturation without causing cell loss. Here, we show that silencing of MeCP2 decreased neurite arborization and synaptogenesis in cultured hippocampal neurons from rat fetal brains. These structural defects were associated with alterations in synaptic transmission and neural network activity. Similar retardation of dendritic growth was also observed in MeCP2-deficient newborn granule cells in the dentate gyrus of adult mouse brains in vivo, demonstrating direct and cell-autonomous effects on individual neurons. These defects, caused by MeCP2 deficiency, were reversed by treatment with the US Food and Drug Administration-approved drug, pentobarbital, in vitro and in vivo, possibly caused by modulation of γ-aminobutyric acid signaling. The results indicate that drugs modulating γ-aminobutyric acid signaling are potential therapeutics for Rett syndrome.

Original languageEnglish
Pages (from-to)477-490
Number of pages14
JournalNeurotherapeutics
Volume12
Issue number2
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Methyl-CpG-Binding Protein 2
Pentobarbital
Rett Syndrome
Aminobutyrates
Neurons
Protein Deficiency
Sequence Deletion
Dentate Gyrus
Brain
Neurites
United States Food and Drug Administration
Synaptic Transmission
Pharmaceutical Preparations
Growth

Keywords

  • dendrites
  • GABA
  • newborn neurons
  • pentobarbital
  • Rett syndrome

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Pharmacology

Cite this

Rescue of Methyl-CpG Binding Protein 2 Dysfunction-induced Defects in Newborn Neurons by Pentobarbital. / Ma, Dongliang; Yoon, Su In; Yang, Chih Hao; Marcy, Guillaume; Zhao, Na; Leong, Wan Ying; Ganapathy, Vinu; Han, Ju; Van Dongen, Antonius M J; Hsu, Kuei Sen; Ming, Guo Li; Augustine, George J.; Goh, Eyleen L K.

In: Neurotherapeutics, Vol. 12, No. 2, 01.04.2015, p. 477-490.

Research output: Contribution to journalArticle

Ma, D, Yoon, SI, Yang, CH, Marcy, G, Zhao, N, Leong, WY, Ganapathy, V, Han, J, Van Dongen, AMJ, Hsu, KS, Ming, GL, Augustine, GJ & Goh, ELK 2015, 'Rescue of Methyl-CpG Binding Protein 2 Dysfunction-induced Defects in Newborn Neurons by Pentobarbital', Neurotherapeutics, vol. 12, no. 2, pp. 477-490. https://doi.org/10.1007/s13311-015-0343-0
Ma, Dongliang ; Yoon, Su In ; Yang, Chih Hao ; Marcy, Guillaume ; Zhao, Na ; Leong, Wan Ying ; Ganapathy, Vinu ; Han, Ju ; Van Dongen, Antonius M J ; Hsu, Kuei Sen ; Ming, Guo Li ; Augustine, George J. ; Goh, Eyleen L K. / Rescue of Methyl-CpG Binding Protein 2 Dysfunction-induced Defects in Newborn Neurons by Pentobarbital. In: Neurotherapeutics. 2015 ; Vol. 12, No. 2. pp. 477-490.
@article{59a4485e7aaa4774a774d07b14db3e8d,
title = "Rescue of Methyl-CpG Binding Protein 2 Dysfunction-induced Defects in Newborn Neurons by Pentobarbital",
abstract = "Rett syndrome is a neurodevelopmental disorder that usually arises from mutations or deletions in methyl-CpG binding protein 2 (MeCP2), a transcriptional regulator that affects neuronal development and maturation without causing cell loss. Here, we show that silencing of MeCP2 decreased neurite arborization and synaptogenesis in cultured hippocampal neurons from rat fetal brains. These structural defects were associated with alterations in synaptic transmission and neural network activity. Similar retardation of dendritic growth was also observed in MeCP2-deficient newborn granule cells in the dentate gyrus of adult mouse brains in vivo, demonstrating direct and cell-autonomous effects on individual neurons. These defects, caused by MeCP2 deficiency, were reversed by treatment with the US Food and Drug Administration-approved drug, pentobarbital, in vitro and in vivo, possibly caused by modulation of γ-aminobutyric acid signaling. The results indicate that drugs modulating γ-aminobutyric acid signaling are potential therapeutics for Rett syndrome.",
keywords = "dendrites, GABA, newborn neurons, pentobarbital, Rett syndrome",
author = "Dongliang Ma and Yoon, {Su In} and Yang, {Chih Hao} and Guillaume Marcy and Na Zhao and Leong, {Wan Ying} and Vinu Ganapathy and Ju Han and {Van Dongen}, {Antonius M J} and Hsu, {Kuei Sen} and Ming, {Guo Li} and Augustine, {George J.} and Goh, {Eyleen L K}",
year = "2015",
month = "4",
day = "1",
doi = "10.1007/s13311-015-0343-0",
language = "English",
volume = "12",
pages = "477--490",
journal = "Neurotherapeutics",
issn = "1933-7213",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Rescue of Methyl-CpG Binding Protein 2 Dysfunction-induced Defects in Newborn Neurons by Pentobarbital

AU - Ma, Dongliang

AU - Yoon, Su In

AU - Yang, Chih Hao

AU - Marcy, Guillaume

AU - Zhao, Na

AU - Leong, Wan Ying

AU - Ganapathy, Vinu

AU - Han, Ju

AU - Van Dongen, Antonius M J

AU - Hsu, Kuei Sen

AU - Ming, Guo Li

AU - Augustine, George J.

AU - Goh, Eyleen L K

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Rett syndrome is a neurodevelopmental disorder that usually arises from mutations or deletions in methyl-CpG binding protein 2 (MeCP2), a transcriptional regulator that affects neuronal development and maturation without causing cell loss. Here, we show that silencing of MeCP2 decreased neurite arborization and synaptogenesis in cultured hippocampal neurons from rat fetal brains. These structural defects were associated with alterations in synaptic transmission and neural network activity. Similar retardation of dendritic growth was also observed in MeCP2-deficient newborn granule cells in the dentate gyrus of adult mouse brains in vivo, demonstrating direct and cell-autonomous effects on individual neurons. These defects, caused by MeCP2 deficiency, were reversed by treatment with the US Food and Drug Administration-approved drug, pentobarbital, in vitro and in vivo, possibly caused by modulation of γ-aminobutyric acid signaling. The results indicate that drugs modulating γ-aminobutyric acid signaling are potential therapeutics for Rett syndrome.

AB - Rett syndrome is a neurodevelopmental disorder that usually arises from mutations or deletions in methyl-CpG binding protein 2 (MeCP2), a transcriptional regulator that affects neuronal development and maturation without causing cell loss. Here, we show that silencing of MeCP2 decreased neurite arborization and synaptogenesis in cultured hippocampal neurons from rat fetal brains. These structural defects were associated with alterations in synaptic transmission and neural network activity. Similar retardation of dendritic growth was also observed in MeCP2-deficient newborn granule cells in the dentate gyrus of adult mouse brains in vivo, demonstrating direct and cell-autonomous effects on individual neurons. These defects, caused by MeCP2 deficiency, were reversed by treatment with the US Food and Drug Administration-approved drug, pentobarbital, in vitro and in vivo, possibly caused by modulation of γ-aminobutyric acid signaling. The results indicate that drugs modulating γ-aminobutyric acid signaling are potential therapeutics for Rett syndrome.

KW - dendrites

KW - GABA

KW - newborn neurons

KW - pentobarbital

KW - Rett syndrome

UR - http://www.scopus.com/inward/record.url?scp=84939968942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939968942&partnerID=8YFLogxK

U2 - 10.1007/s13311-015-0343-0

DO - 10.1007/s13311-015-0343-0

M3 - Article

C2 - 25753729

AN - SCOPUS:84939968942

VL - 12

SP - 477

EP - 490

JO - Neurotherapeutics

JF - Neurotherapeutics

SN - 1933-7213

IS - 2

ER -